Examining the association between exposome score for schizophrenia and functioning in schizophrenia, siblings, and healthy controls: Results from the EUGEI study

Author:

Erzin Gamze,Pries Lotta-Katrin,van Os JimORCID,Fusar-Poli LauraORCID,Delespaul Philippe,Kenis Gunter,Luykx Jurjen J.ORCID,Lin Bochao D.,Richards Alexander L.,Akdede Berna,Binbay Tolga,Altınyazar Vesile,Yalınçetin Berna,Gümüş-Akay GüvemORCID,Cihan Burçin,Soygür Haldun,Ulaş Halis,Cankurtaran Eylem Şahin,Kaymak Semra Ulusoy,Mihaljevic Marina M.,Andric-Petrovic Sanja,Mirjanic Tijana,Bernardo MiguelORCID,Mezquida GiselaORCID,Amoretti Silvia,Bobes JulioORCID,Saiz Pilar A.,García-Portilla Maria Paz,Sanjuan Julio,Aguilar Eduardo J.,Santos Jose Luis,Jiménez-López Estela,Arrojo Manuel,Carracedo Angel,López Gonzalo,González-Peñas Javier,Parellada Mara,Maric Nadja P.,Atbaşoğlu Cem,Ucok Alp,Alptekin Köksal,Saka Meram Can,Arango Celso,O’Donovan Micheal C.,Rutten Bart P. F.,Guloksuz SinanORCID,

Abstract

Abstract Background A cumulative environmental exposure score for schizophrenia (exposome score for schizophrenia [ES-SCZ]) may provide potential utility for risk stratification and outcome prediction. Here, we investigated whether ES-SCZ was associated with functioning in patients with schizophrenia spectrum disorder, unaffected siblings, and healthy controls. Methods This cross-sectional sample consisted of 1,261 patients, 1,282 unaffected siblings, and 1,525 healthy controls. The Global Assessment of Functioning (GAF) scale was used to assess functioning. ES-SCZ was calculated based on our previously validated method. The association between ES-SCZ and the GAF dimensions (symptom and disability) was analyzed by applying regression models in each group (patients, siblings, and controls). Additional models included polygenic risk score for schizophrenia (PRS-SCZ) as a covariate. Results ES-SCZ was associated with the GAF dimensions in patients (symptom: B = −1.53, p-value = 0.001; disability: B = −1.44, p-value = 0.001), siblings (symptom: B = −3.07, p-value < 0.001; disability: B = −2.52, p-value < 0.001), and healthy controls (symptom: B = −1.50, p-value < 0.001; disability: B = −1.31, p-value < 0.001). The results remained the same after adjusting for PRS-SCZ. The degree of associations of ES-SCZ with both symptom and disability dimensions were higher in unaffected siblings than in patients and controls. By analyzing an independent dataset (the Genetic Risk and Outcome of Psychosis study), we replicated the results observed in the patient group. Conclusions Our findings suggest that ES-SCZ shows promise for enhancing risk prediction and stratification in research practice. From a clinical perspective, ES-SCZ may aid in efforts of clinical characterization, operationalizing transdiagnostic clinical staging models, and personalizing clinical management.

Publisher

Royal College of Psychiatrists

Subject

Psychiatry and Mental health

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3